RxDoctor Payments Data

Emily Shaffer, PA

Gynecologic Oncology · Fairfield, OHNPI 1346924081

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $612 of the $711 with a category attached, or 86.1%. It is spread thinly across 14 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $447, more than ten times the $14 reported in 2023. That places this record below the midpoint for gynecologic oncology clinicians in OH, where the typical reported total is $1,215.

$711in general payments, 2019–2025

Across 27 payments — averaging $26.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$142
  • Novartis$117
  • Incyte Corporation$117
  • Merck$65
  • AVEO Pharmaceuticals, Inc.$43
  • Takeda Pharmaceuticals U.S.A., Inc.$42
  • plus $185 from 8 others

What the payments were for

  • Food & beverage$61286%
  • Education$9914%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$711 in reported general payments places this provider in the 35th percentile of 62 gynecologic oncology providers in Ohio.

See all gynecologic oncology providers in Ohio

Medicare billing

Part B allowed, 2024
$32,403
Medicare patients
235
Services billed
689

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremarinEstrogens, Conjugated20$10,036
Estradiol39$3,038
YuvafemEstradiol15$1,752
ValacyclovirValacyclovir Hcl17$842
Clobetasol Propionate35$822
Mometasone Furoate46$810
Nystatin23$478
Oxybutynin Chloride12$207
Fluconazole17$109
Alendronate Sodium22$78
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst16$73
Oxycodone Hcl14$40

Paid to pharmacies, not to this prescriber.

Other gynecologic oncology in Fairfield

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →